Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,170.00
Bid: 11,500.00
Ask: 12,270.00
Change: 0.00 (0.00%)
Spread: 770.00 (6.696%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: FTSE Suffers Worst Fall Of 2014 As Fear Grips Market

Wed, 15th Oct 2014 16:33

LONDON (Alliance News) - UK stock indices closed significantly lower Wednesday, with the FTSE 100 suffering its worst one-day fall of the year so far. The sell-off was mirrored across Europe as markets were gripped by concern about a slowdown in growth amid disappointing economic data from around the world.

Volatility has returned to the markets in a big way, with the VIX volatility index reaching its highest level since since mid-2012, while global bond yields plunged to their lowest levels of the year and gold reached its highest level in more than a month as investors fled to the traditional safe havens.

The FTSE 100 ended the day down 2.8% at 6,211.64, shedding 181 points, which leaves the UK's leading index at its lowest level in 15 months. The mid-cap FTSE 250 ended the day down 1.7% at 14,426.74, and the small-cap AIM All-Share closed down 2.4% at 681.22, its lowest level in almost two years.

Major European equity markets also suffered heavy falls, with the French CAC 40 down a massive 3.6%, and the German DAX 30 down 2.9%. US stocks continued lower, with the DJIA, S&P 500 and Nasdaq Composite all down about 1.5% at the time of the European close. The DJIA slipped below 16,000 for the first time since February.

European indices started lower Wednesday amid ongoing concerns over the health of the eurozone economy, after early data from Germany showed consumer prices stagnated in September, for the second consecutive month. Those concerns were only compounded by continued declines in the price of oil, with Brent crude hitting a near four-year low in early trade, bottoming at USD83.35 per barrel.

Investors also remain concerned over the spread of Ebola, after a second healthcare worker in the US was confirmed to have caught the virus. The infected person was on an internal US flight on Monday night, and authorities are looking to contact the other passengers on the flight.

Global indices unwound further in afternoon trade after some disappointing US economic data showed retail sales there fell by 0.3% month-on-month in September, exceeding expectations for a 0.1% fall. The New York manufacturing index also contracted sharply in September, coming in at 6.17, down from 27.54 in August, while US producer price growth also turned negative, recording a month fall of 0.1%. The apparent slowing in US economic activity comes as a particular concern to investors given that it coincides with the end of the Federal Reserves quantitative easing programme later this month.

In London, Shire led the FTSE 100 lower from the outset Wednesday, plunging by a quarter at the open after US authorities appeared to get their way when AbbVie Inc said it is reconsidering its takeover of the Irish drug maker. The deal, which valued Shire at GBP32 billion, had been thrown into some doubt after US Treasury Secretary Jack Lew announced new measures last month to make so-called tax inversion deals less appealing. The news that AbbVie actually has gotten cold feed still took the markets by surprise, and Shire ended the day heavily lower at GBP39.43, not far from its mid-June price, when it originally rejected an advance from AbbVie.

Oil stocks were weighed down by oil prices, with Tullow Oil dropping 4.7%, Royal Dutch Shell falling 2.3%, Enquest down 5.7%, and Cairn Energy down 3.3%. BG Group held up relatively well against the sector decline, ending down just 0.5% after announcing that it poached Helge Lund from Norwegian rival Statoil to be its new chief executive from next March. Deutsche Bank sees the appointment as a positive step for BG, calling Lund an "industry heavyweight". Separately, BG Group said it had started production on the Iracema area in block BM-S-11 in the Santos Basin offshore Brazil early.

Royal Mail was the only FTSE 100 stock to record any significant gains, significantly outperforming the market and closing up 1.9% following the news Tuesday that it has sold one of its sites that is "recognised a surplus" for GBP111 million. Analysts at Berenberg say that the sale price was 85% above its own valuation, therefore indicating that Royal Mail shares may be significantly undervalued.

FTSE 250 listed CSR surged 30% after the semiconductor producer said it agreed to be acquired by US-based semiconductor company Qualcomm Inc for GBP1.6 billion in cash, a deal that comes after it has been in talks about a potential takeover with Microchip Technology Inc since August. The 900 pence a share bid from the US semiconductor group comes after CSR rebuffed an approach from Microchip Technology for being too low in August.

Balfour Beatty rose 11% on the news that it has poached the chief executive of defence products company QinetiQ Group to be its own CEO from January 1, 2015, a job that will involve turning the struggling company around after a string of profit warnings, a failed merger attempt from rival Carillion, and the disputed sale of its US project management business. Analysts have been positive over the appointment of new CEO Leo Quinn. Jefferies says he has a good track record as a turnaround specialist. QinetiQ was the worst performer in the FTSE 250, closing down 12%.

The most positive economic news of the day came from the UK Wednesday, where the unemployment rate fell to a six year low of 6.0% in August from 6.2% in July, exceeding expectations for a fall to 6.1%. Average earnings also improved a little faster that expected, rising by 0.9% in August, up from 0.8% in July and beating the expectation for the growth rate to remain unchanged.

A combination of the better UK data and weakness in the US dollar after the poor data across the pond sent the currency pair briefly back above USD1.60, although at the time of the equity market close the pound has weakened again to trade at USD1.5955.

Safe haven demand sent gold up to its highest level in more than a month, peaking at USD1,249.61 per ounce. The firmer price provided support for precious metal miner Fresnillo, which closed up 0.4% after raising its 2014 gold production target to 590,000 ounces.

There may be more volatility still to come Wednesday, with European Central Bank President Mario Draghi due to speak at 1900 BST from an International Monetary Fund event in Washington. The Federal Reserve's Beige Book of economic conditions is also due to be released at the same time.

Looking towards Thursday, eurozone consumer inflation data will be the morning focus, while from the US in the afternoon there is a raft of data including jobless claims and industrial production, as well as a number of speeches from Fed officials.

In the UK corporate calendar Thursday, drinks giant Diageo is due to make an interim management statement, as are Evraz, Mondi, and Man Group, among others. British Sky Broadcasting is due to release first-quarter results.

By Jon Darby; jondarby@alliancenews.com; @jondarby100

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.